Medication errors in hospitalised children

Elizabeth Manias1, Sharon Kinney, Noel Cranswick

  • 1Melbourne School of Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.

Insights

This study analyzed 2753 medication errors in children at an Australian hospital. Communication issues and failure to follow procedures were key factors, highlighting the need for improved medication safety strategies.

Area of Science:

  • Pediatric patient safety
  • Medication error analysis
  • Healthcare quality improvement

Background:

  • Medication errors pose a significant risk to pediatric patients.
  • Understanding the specific types and causes of errors is crucial for developing effective interventions.

Purpose of the Study:

  • To characterize medication errors in children at an Australian hospital.
  • To identify the types, causes, and contributing factors of these errors.

Main Methods:

  • Retrospective clinical audit of reported medication errors.
  • Analysis of data from an online incident reporting system over a 4-year period.

Main Results:

  • 2753 medication errors reported; overall rate of 0.31%.
  • Most errors occurred before reaching the child (27.2%) or reached the child requiring monitoring (55.2%).
  • Common errors: overdose (21.0%), dose omission (12.4%). Communication failures (misreading orders) and transfer communication were major causes.

Conclusions:

  • Medication errors involving analgesics, anti-infectives, cardiovascular, fluids/electrolytes, and anticlotting agents require targeted strategies.
  • Enhanced support for healthcare professionals in managing these medications is essential.
  • Focus on communication and adherence to policies is needed to reduce pediatric medication errors.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410